Navigate Up

UPMC/University of Pittsburgh Schools of the Health Sciences
For Journalists
Manager
Telephone: 412-996-5852
Patient & Other Inquiries

​Pitt Rheumatology Division Named Part of NIH Network for Lupus and Rheumatoid Arthritis Study

PITTSBURGH, Sept. 24, 2014 - The National Institutes of Health (NIH) announced today that it has awarded five-year grants to 11 research centers across the United States in a private-public partnership designed to better identify and develop new diagnostics and drugs for rheumatoid arthritis (RA) and lupus. The Division of Rheumatology and Clinical Immunology of the University of Pittsburgh School of Medicine, led by chief Larry W. Moreland, M.D., has been chosen as one of the research sites – the only one between the states of New York and Colorado.
 
“From our perspective, this is a tremendous collaborative effort involving physicians and researchers across disciplines, including basic scientists, clinical researchers, orthopaedic surgeons, radiologists and numerous clinical rheumatologists,” said Dr. Moreland. The lab of Mandy McGeachy, Ph.D., assistant professor of medicine, will direct the basic science effort for the Pitt team.
 
  • Pitt’s research team will collect data from a large group of patients already participating in NIH-funded research. The project aims to unravel biological pathways involved in RA by examining surgical tissue samples, performing ultrasound-guided biopsies of inflamed joints, and utilizing specialized tissue processing for immune-cell analytics, as well as conducting other tests. The team also has proposed a clinical study in which patients who haven’t responded to first-line therapy with methotrexate will be randomized to receive a biologic therapy.
  • Members of the 11 network centers – totaling 18 principal investigators – will collaborate as a consortium, starting with a meeting scheduled for the end of October.
  • The incentivized research plan consists of a seed grant from the NIH, which then may award larger sums moving forward dependent upon the progress of the research and further studies to follow.
The NIH news release can be found on its site.

UPMC | Affiliated with the University of Pittsburgh Schools of the Health Sciences Supplemental content provided by Healthwise, Incorporated. To learn more, visit www.healthwise.org

For help in finding a doctor or health service that suits your needs, call the UPMC Referral Service at 412-647-UPMC (8762) or 1-800-533-UPMC (8762). Select option 1.

UPMC is an equal opportunity employer. UPMC policy prohibits discrimination or harassment on the basis of race, color, religion, ancestry, national origin, age, sex, genetics, sexual orientation, gender identity, marital status, familial status, disability, veteran status, or any other legally protected group status. Further, UPMC will continue to support and promote equal employment opportunity, human dignity, and racial, ethnic, and cultural diversity. This policy applies to admissions, employment, and access to and treatment in UPMC programs and activities. This commitment is made by UPMC in accordance with federal, state, and/or local laws and regulations.

Medical information made available on UPMC.com is not intended to be used as a substitute for professional medical advice, diagnosis, or treatment. You should not rely entirely on this information for your health care needs. Ask your own doctor or health care provider any specific medical questions that you have. Further, UPMC.com is not a tool to be used in the case of an emergency. If an emergency arises, you should seek appropriate emergency medical services.

UPMC
Pittsburgh, PA, USA | UPMC.com